Jean-Christophe Lagier

InstitutionAix Marseille Univ
AddressMarseille
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 55 Covid-19 publications, with a maximum of 11 publications in January 2021
    All Publications
    Bar chart showing 276 publications over 14 distinct years, with a maximum of 48 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62). PMID: 34413139.
      Citations: 28     Fields:    Translation:Humans
    2. Colson P, Devaux CA, Lagier JC, Gautret P, Raoult D. A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants. J Clin Med. 2021 Jul 24; 10(15). PMID: 34362060.
      Citations: 2     
    3. Bouam A, Vincent JJ, Le Glass E, Almeras L, Levy PY, Tissot-Dupont H, Lagier JC, Fournier PE, Raoult D, Drancourt M. Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening. J Clin Med. 2021 Jun 16; 10(12). PMID: 34208430.
      Citations:    
    4. Dao TL, Hoang VT, Colson P, Lagier JC, Million M, Raoult D, Levasseur A, Gautret P. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med. 2021 Jun 15; 10(12). PMID: 34203844.
      Citations: 2     
    5. Osman IO, Melenotte C, Brouqui P, Million M, Lagier JC, Parola P, Stein A, La Scola B, Meddeb L, Mege JL, Raoult D, Devaux CA. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732. PMID: 34194422.
      Citations: 5     Fields:    Translation:HumansCells
    6. Roussel Y, Million M, Chabriere E, Lagier JC, Raoult D. Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United States. Clin Infect Dis. 2021 06 01; 72(11):e928. PMID: 33086376.
      Citations:    Fields:    Translation:Humans
    7. Dao TL, Hoang VT, Nguyen NN, Delerce J, Chaudet H, Levasseur A, Lagier JC, Raoult D, Colson P, Gautret P. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6. PMID: 34044152.
      Citations: 4     Fields:    Translation:Humans
    8. Drancourt M, Cortaredona S, Melenotte C, Amrane S, Eldin C, La Scola B, Parola P, Million M, Lagier JC, Raoult D, Colson P. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5). PMID: 34065871.
      Citations: 2     Fields:    Translation:Humans
    9. Colson P, Levasseur A, Delerce J, Pinault L, Dudouet P, Devaux C, Fournier PE, La Scola B, Lagier JC, Raoult D. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage. Clin Microbiol Infect. 2021 Sep; 27(9):1352.e1-1352.e5. PMID: 33991677.
      Citations: 8     Fields:    Translation:HumansCells
    10. Lagier JC, Amrane S, Mailhe M, Gainnier M, Arlotto S, Gentile S, Raoult D. High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report. Int J Infect Dis. 2021 Jul; 108:1-3. PMID: 33823281.
      Citations: 4     Fields:    Translation:Humans
    11. Fournier PE, Colson P, Levasseur A, Devaux CA, Gautret P, Bedotto M, Delerce J, Brechard L, Pinault L, Lagier JC, Fenollar F, Raoult D. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant. Int J Infect Dis. 2021 May; 106:228-236. PMID: 33785459.
      Citations: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    12. Brouqui P, Colson P, Melenotte C, Houhamdi L, Bedotto M, Devaux C, Gautret P, Gautret P, Million M, Parola P, Stoupan D, La Scola B, Lagier JC, Raoult D. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537. PMID: 33675046.
      Citations: 10     Fields:    Translation:Humans
    13. Devaux CA, Lagier JC, Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne). 2021; 8:640073. PMID: 33681266.
      Citations: 11     
    14. Castelli M, Maurin A, Bartoli A, Dassa M, Marchi B, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Cortaredona S, Jacquier A, Gaubert JY, Habert P. Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21. PMID: 33594500.
      Citations:    
    15. Dubourg G, Lagier JC, Brouqui P, Casalta JP, Jacomo V, La Scola B, Rolain JM, Raoult D. Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients? J Microbiol Immunol Infect. 2021 Oct; 54(5):997-1000. PMID: 33632620.
      Citations: 1     Fields:    Translation:Humans
    16. Colson P, Levasseur A, Gautret P, Fenollar F, Thuan Hoang V, Delerce J, Bitam I, Saile R, Maaloum M, Padane A, Bedotto M, Brechard L, Bossi V, Ben Khedher M, Chaudet H, Million M, Tissot-Dupont H, Lagier JC, Mboup S, Fournier PE, Raoult D. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980. PMID: 33535105.
      Citations: 12     Fields:    Translation:Humans
    17. Nguyen NN, Hoang VT, Lagier JC, Raoult D, Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021 Jun; 27(6):931-932. PMID: 33418020.
      Citations: 11     Fields:    Translation:Humans
    18. Gautret P, Lagier JC, Honoré S, Hoang VT, Colson P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243. PMID: 33408014.
      Citations: 2     Fields:    Translation:Humans
    19. Gautret P, Hoang VT, Chaudet H, Lagier JC, Raoult D. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. Int J Antimicrob Agents. 2021 01; 57(1):106244. PMID: 33408015.
      Citations:    Fields:    Translation:Humans
    20. Gautret P, Honoré S, Lagier JC, Raoult D. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. Int J Antimicrob Agents. 2021 Jan; 57(1):106236. PMID: 33408025.
      Citations: 1     Fields:    Translation:Humans
    21. Gautret P, Hoang VT, Lagier JC, Raoult D. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. Int J Antimicrob Agents. 2021 01; 57(1):106237. PMID: 33408027.
      Citations:    Fields:    Translation:Humans
    22. Gautret P, Hoang VT, Lagier JC, Raoult D. Response to advances statistical methods and designs for clinical trials for COVID-19. Int J Antimicrob Agents. 2021 01; 57(1):106235. PMID: 33408028.
      Citations:    Fields:    Translation:Humans
    23. Gautret P, Hoang VT, Lagier JC, Raoult D. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. Int J Antimicrob Agents. 2021 Jan; 57(1):106239. PMID: 33408029.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    24. Colson P, La Scola B, Lagier JC, Gautret P, Raoult D. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238. PMID: 33408030.
      Citations:    Fields:    Translation:Humans
    25. Gautret P, Hoang VT, Honoré S, Roussel Y, Million M, Lagier JC, Raoult D. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 01; 57(1):106241. PMID: 33408031.
      Citations: 1     Fields:    Translation:Humans
    26. Gautret P, Lagier JC, Honoré S, Hoang VT, Raoult D. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106242. PMID: 33408033.
      Citations: 1     Fields:    Translation:Humans
    27. Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, Leone M, La Scola B, Devaux C, Gaubert JY, Mege JL, Vitte J, Melenotte C, Rolain JM, Parola P, Lagier JC, Brouqui P, Raoult D. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184. PMID: 33356661.
      Citations: 19     Fields:    Translation:Humans
    28. Boschi C, Hoang VT, Giraud-Gatineau A, Ninove L, Lagier JC, La Scola B, Gautret P, Raoult D, Colson P. Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881. PMID: 33230812.
      Citations: 4     Fields:    Translation:HumansCells
    29. Million M, Giraud-Gatineau A, Lagier JC, Parola P, Gautret P, Raoult D. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Med Infect Dis. 2021 Jan-Feb; 39:101954. PMID: 33316396.
      Citations: 1     Fields:    Translation:Humans
    30. Lasbleiz A, Cariou B, Darmon P, Soghomonian A, Ancel P, Boullu S, Houssays M, Romain F, Lagier JC, Boucekine M, Resseguier N, Gourdy P, Pichelin M, Wargny M, Dutour A, Gaborit B. Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study. J Clin Med. 2020 Nov 20; 9(11). PMID: 33233575.
      Citations: 3     
    31. Castelli M, Maurin A, Bartoli A, Dassa M, Marchi B, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Cortaredona S, Jacquier A, Gaubert JY, Habert P. Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117. PMID: 33201409.
      Citations: 4     
    32. Colson P, Finaud M, Levy N, Lagier JC, Raoult D. Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect. 2021 04; 82(4):84-123. PMID: 33207255.
      Citations: 15     Fields:    Translation:Humans
    33. Edouard S, Colson P, Melenotte C, Di Pinto F, Thomas L, La Scola B, Million M, Tissot-Dupont H, Gautret P, Stein A, Brouqui P, Parola P, Lagier JC, Raoult D, Drancourt M. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371. PMID: 33179133.
      Citations: 14     Fields:    Translation:Humans
    34. Leger T, Jacquier A, Barral PA, Castelli M, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Bartoli A, Gaubert JY, Habert P. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407. PMID: 33141845.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    35. Brouqui P, Amrane S, Million M, Cortaredona S, Parola P, Lagier JC, Raoult D. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238. PMID: 33130200.
      Citations: 19     Fields:    Translation:Humans
    36. Gautret P, Colson P, Lagier JC, Camoin-Jau L, Giraud-Gatineau A, Boudjema S, Finance J, Chaudet H, Raoult D. Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19. PMID: 33038556.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    37. Million M, Roussel Y, Lagier JC, Raoult D. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. Clin Microbiol Infect. 2021 01; 27(1):132-133. PMID: 32980527.
      Citations: 1     Fields:    Translation:Humans
    38. Colson P, Esteves-Vieira V, Giraud-Gatineau A, Zandotti C, Filosa V, Chaudet H, Lagier JC, Raoult D. Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France. Int J Infect Dis. 2020 Dec; 101:121-125. PMID: 32976991.
      Citations: 1     Fields:    Translation:HumansCells
    39. Boudjema S, Finance J, Coulibaly F, Meddeb L, Tissot-Dupont H, Michel M, Lagier JC, Million M, Radulesco T, Michel J, Brouqui P, Raoult D, Fenollar F, Parola P. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875. PMID: 32898703.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    40. Colson P, Tissot-Dupont H, Morand A, Boschi C, Ninove L, Esteves-Vieira V, Gautret P, Brouqui P, Parola P, Lagier JC, Zandotti C, Million M, La Scola B, Raoult D. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987. PMID: 32845413.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    41. Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, Honoré S, Gaubert JY, Fournier PE, Tissot-Dupont H, Chabrière E, Stein A, Deharo JC, Fenollar F, Rolain JM, Obadia Y, Jacquier A, La Scola B, Brouqui P, Drancourt M, Parola P, Raoult D. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791. PMID: 32593867.
      Citations: 103     Fields:    Translation:HumansCellsPHPublic Health
    42. Million M, Gautret P, Colson P, Roussel Y, Dubourg G, Chabriere E, Honore S, Rolain JM, Fenollar F, Fournier PE, Lagier JC, Parola P, Brouqui P, Raoult D. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709. PMID: 33088574.
      Citations: 26     
    43. Gautret P, Colson P, Lagier JC, Parola P, Raoult D. Does spitting in public play a role in transmitting SARS-CoV-2? Travel Med Infect Dis. 2020 Jul - Aug; 36:101759. PMID: 32492484.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    44. Giraud-Gatineau A, Colson P, Jimeno MT, Zandotti C, Ninove L, Boschi C, Lagier JC, La Scola B, Chaudet H, Raoult D. Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Int J Infect Dis. 2020 Jul; 96:154-156. PMID: 32389848.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    45. Morand A, Roquelaure B, Colson P, Amrane S, Bosdure E, Raoult D, Lagier JC, Fabre A. Child with liver transplant recovers from COVID-19 infection. A case report. Arch Pediatr. 2020 Jul; 27(5):275-276. PMID: 32402433.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    46. Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, Hocquart M, Mailhe M, Esteves-Vieira V, Doudier B, Aubry C, Correard F, Giraud-Gatineau A, Roussel Y, Berenger C, Cassir N, Seng P, Zandotti C, Dhiver C, Ravaux I, Tomei C, Eldin C, Tissot-Dupont H, Honoré S, Stein A, Jacquier A, Deharo JC, Chabrière E, Levasseur A, Fenollar F, Rolain JM, Obadia Y, Brouqui P, Drancourt M, La Scola B, Parola P, Raoult D. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738. PMID: 32387409.
      Citations: 169     Fields:    Translation:HumansCellsPHPublic Health
    47. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, Mailhe M, Doudier B, Aubry C, Amrane S, Seng P, Hocquart M, Eldin C, Finance J, Vieira VE, Tissot-Dupont HT, Honoré S, Stein A, Million M, Colson P, La Scola B, Veit V, Jacquier A, Deharo JC, Drancourt M, Fournier PE, Rolain JM, Brouqui P, Raoult D. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663. PMID: 32289548.
      Citations: 282     Fields:    Translation:HumansCellsPHPublic Health
    48. Colson P, Lagier JC, Baudoin JP, Bou Khalil J, La Scola B, Raoult D. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020 Aug; 39(8):1601-1603. PMID: 32270412.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    49. Eldin C, Lagier JC, Mailhe M, Gautret P. Probable aircraft transmission of Covid-19 in-flight from the Central African Republic to France. Travel Med Infect Dis. 2020 May - Jun; 35:101643. PMID: 32247016.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    50. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949. PMID: 32205204.
      Citations: 1940     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    51. Amrane S, Tissot-Dupont H, Doudier B, Eldin C, Hocquart M, Mailhe M, Dudouet P, Ormières E, Ailhaud L, Parola P, Lagier JC, Brouqui P, Zandotti C, Ninove L, Luciani L, Boschi C, La Scola B, Raoult D, Million M, Colson P, Gautret P. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632. PMID: 32205269.
      Citations: 51     Fields:    Translation:HumansCellsPHPublic Health
    52. Lagier JC, Colson P, Tissot Dupont H, Salomon J, Doudier B, Aubry C, Gouriet F, Baron S, Dudouet P, Flores R, Ailhaud L, Gautret P, Parola P, La Scola B, Raoult D, Brouqui P. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624. PMID: 32179125.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    53. Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932. PMID: 32145363.
      Citations: 317     Fields:    Translation:CellsPHPublic Health
    54. Colson P, La Scola B, Esteves-Vieira V, Ninove L, Zandotti C, Jimeno MT, Gazin C, Bedotto M, Filosa V, Giraud-Gatineau A, Chaudet H, Brouqui P, Lagier JC, Raoult D. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8). PMID: 32127122.
      Citations: 2     Fields:    Translation:HumansCells
    55. Griffiths K, Charrel R, Lagier JC, Nougairede A, Simon F, Parola P, Brouqui P, Gautret P. Infections in symptomatic travelers returning from the Arabian peninsula to France: A retrospective cross-sectional study. Travel Med Infect Dis. 2016 Jul-Aug; 14(4):414-6. PMID: 27185404.
      Citations: 8     Fields:    Translation:HumansCells
    56. Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, Salez N, Memish ZA, Al Masri M, Lagier JC, Million M, Raoult D, Brouqui P, Parola P. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30. PMID: 24656283.
      Citations: 41     Fields:    Translation:HumansCells
    Lagier's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (328)
    Explore
    _
    Co-Authors (328)
    Explore
    _
    Similar People (60)
    Explore
    _